TRAX · Forms 3, 4, 5
Insider trades at First Tracks Biotherapeutics, Inc.
1 insider sold $1.8M of First Tracks Biotherapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for First Tracks Biotherapeutics, Inc. (TRAX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| John A Orwin | Director | Option exercise | 1,300 | Form 4 | |||
| J. Anthony Ware | Director | Option exercise | 39,265 | $5.74 | $225K | Form 4 | |
| J. Anthony Ware | Director | Sell | 39,265 | $44.78 | $1.8M | Form 4 | |
| Benjamin Stone | Chief Business Officer | Options or other derivatives | Form 4 | ||||
| Paul F. Lizzul | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Daniel Faga | President, CEO | Options or other derivatives | Form 4 | ||||
| Benjamin Stone | Chief Business Officer | Options or other derivatives | Form 4 | ||||
| Paul F. Lizzul | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Daniel Faga | President, CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.